Study of HST5040 in Subjects With Propionic or Methylmalonic Acidemia

Stopped The decision to terminate the study was based on business considerations by the Sponsor.

Conditions

• Methylmalonic Acidemia
• Propionic Acidemia

Interventions

• DRUG: HST5040
• DRUG: Placebo

Sponsor

HemoShear Therapeutics